Ameriprise’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,396
| Closed | -$3M | – | 4102 |
|
|
2021
Q3 | $3M | Sell |
17,396
-536,878
| -97% | -$92.4M | ﹤0.01% | 2697 |
|
|
2021
Q2 | $69.6M | Buy |
554,274
+566
| +0.1% | +$71K | 0.02% | 651 |
|
|
2021
Q1 | $75.1M | Sell |
553,708
-2,174
| -0.4% | -$295K | 0.03% | 605 |
|
|
2020
Q4 | $71.1M | Sell |
555,882
-271,032
| -33% | -$34.7M | 0.03% | 588 |
|
|
2020
Q3 | $93.1M | Buy |
826,914
+435,539
| +111% | +$49M | 0.04% | 447 |
|
|
2020
Q2 | $37.3M | Buy |
391,375
+279,156
| +249% | +$26.6M | 0.02% | 733 |
|
|
2020
Q1 | $10.1M | Buy |
+112,219
| New | +$10.1M | 0.01% | 1380 |
|
|
2019
Q1 | – | Sell |
-23,004
| Closed | -$1M | – | 3780 |
|
|
2018
Q4 | $1M | Sell |
23,004
-10
| -0% | -$436 | ﹤0.01% | 2933 |
|
|
2018
Q3 | $1.32M | Buy |
+23,014
| New | +$1.32M | ﹤0.01% | 2967 |
|
|
2017
Q4 | – | Sell |
-33,430
| Closed | -$1.25M | – | 3756 |
|
|
2017
Q3 | $1.25M | Buy |
+33,430
| New | +$1.25M | ﹤0.01% | 2866 |
|
|
2015
Q1 | – | Sell |
-23,317
| Closed | -$908K | – | 3860 |
|
|
2014
Q4 | $908K | Buy |
+23,317
| New | +$908K | ﹤0.01% | 2917 |
|